NYSEMKT:DXR
Daxor Corp Stock News
$9.65
+0 (+0%)
At Close: Apr 26, 2024
50 Stocks Moving In Tuesday's Mid-Day Session
05:03pm, Tuesday, 03'rd Mar 2020
Gainers
Superconductor Technologies Inc. (NASDAQ: SCON) shares jumped 107.1% to $0.4079. Superconductor Technologies and Allied Integral United announced a merger agreement....
Mid-Morning Market Update: Markets Open Higher; Target Posts Mixed Q4 results
03:14pm, Tuesday, 03'rd Mar 2020
Following the market opening Tuesday, the Dow traded up 0.27% to 26,774.19 while the NASDAQ rose 0.48% to 8,996.28. The S&P also rose, gaining 0.44% to 3,103.90. Coronavirus...
Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market
02:23pm, Tuesday, 03'rd Mar 2020
Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measuremen
Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces active engagement wit
DAXOR CORPORATION ANNOUNCES RISE IN KIT SALES AND FILES FORM N-CSR FOR 2019
12:55pm, Monday, 02'nd Mar 2020
Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today filed a Form N-CSR disclosing its
La bataille de l’apprentissage 2.0 : les tutos font la nique aux MOOC
03:00pm, Sunday, 01'st Mar 2020
A l’heure de la digitalisation croissante de l’économie, l’éducation n’échappe pas au mouvement. L’enseignement en ligne à distance avec les MOOC semblaient avoir une longueur d’avance
Daxor says research demonstrates superiority of BVA-100 in critical care DXR
01:55pm, Thursday, 20'th Feb 2020
Daxor says research demonstrates superiority of BVA-100 in critical care DXR
New Research Further Demonstrates Clinical Superiority of Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
01:30pm, Thursday, 20'th Feb 2020
NEW YORK, Feb. 20, 2020 -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume.
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 49th Congress
01:00pm, Wednesday, 12'th Feb 2020
Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces it will be attending th
New advice issued to dog owners as vomiting virus cases rise
09:25am, Monday, 10'th Feb 2020
There have been nearly 500 cases of the virus which leaves dogs vomiting for days
Here's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO Pay
04:20pm, Tuesday, 31'st Dec 2019
In 2016 Michael Feldschuh was appointed CEO of Daxor Corporation (NYSEMKT:DXR). First, this article will compare CEO...
Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin
01:00pm, Thursday, 21'st Nov 2019
Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from The Yale
